Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pertti J Neuvonen

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
Pharmacogenetics and Genomics|September 17, 2008
Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rateMarja K Pasanen, Tatu A Miettinen, Helena Gylling, et al.
Clinical Pharmacology and Therapeutics|March 7, 2003
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprololJari J Lilja, Janne T Backman, Jouko Laitila, et al.
British Journal of Clinical Pharmacology|July 27, 2005
Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinideMikko Niemi, Janne T Backman, Laura Juntti-Patinen, et al.
Clinical Pharmacology and Therapeutics|April 3, 2004
Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interactionMarika T Granfors, Janne T Backman, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinideLauri I Kajosaari, Janne T Backman, Mikko Neuvonen, et al.
Journal of Clinical Psychopharmacology|April 22, 2011
Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteersAntti Liukas, Nora M Hagelberg, Kristiina Kuusniemi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomesJun-Sheng Wang, Mikko Neuvonen, Xia Wen, et al.
Journal of Clinical Pharmacology|April 20, 2010
Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskirenTuija Tapaninen, Janne T Backman, Kaisa J Kurkinen, et al.
Basic & Clinical Pharmacology & Toxicology|July 7, 2005
Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8Aleksi Tornio, Marja K Pasanen, Jouko Laitila, et al.
European Journal of Clinical Pharmacology|November 8, 2007
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanylTeijo I Saari, Kari Laine, Mikko Neuvonen, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
Pharmacogenetics and Genomics|September 17, 2008
Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rateMarja K Pasanen, Tatu A Miettinen, Helena Gylling, et al.
Clinical Pharmacology and Therapeutics|March 7, 2003
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprololJari J Lilja, Janne T Backman, Jouko Laitila, et al.
British Journal of Clinical Pharmacology|July 27, 2005
Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinideMikko Niemi, Janne T Backman, Laura Juntti-Patinen, et al.
Clinical Pharmacology and Therapeutics|April 3, 2004
Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interactionMarika T Granfors, Janne T Backman, Mikko Neuvonen, et al.
British Journal of Clinical Pharmacology|September 18, 2004
Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinideLauri I Kajosaari, Janne T Backman, Mikko Neuvonen, et al.
Journal of Clinical Psychopharmacology|April 22, 2011
Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteersAntti Liukas, Nora M Hagelberg, Kristiina Kuusniemi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomesJun-Sheng Wang, Mikko Neuvonen, Xia Wen, et al.
Journal of Clinical Pharmacology|April 20, 2010
Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskirenTuija Tapaninen, Janne T Backman, Kaisa J Kurkinen, et al.
Basic & Clinical Pharmacology & Toxicology|July 7, 2005
Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8Aleksi Tornio, Marja K Pasanen, Jouko Laitila, et al.
European Journal of Clinical Pharmacology|November 8, 2007
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanylTeijo I Saari, Kari Laine, Mikko Neuvonen, et al.
Pageof 20